Health and Fitness Health and Fitness
Wed, March 28, 2012
[ Wed, Mar 28th 2012 ] - Market Wire
Warnex Debentures in Default

Optimer Pharmaceuticals to Present at the 11th Annual Needham Healthcare Conference


Published on 2012-03-28 05:06:06 - Market Wire
  Print publication without navigation


Optimer Pharmaceuticals to Present at the 11th Annual Needham Healthcare Conference -- SAN DIEGO, March 28, 2012 /PRNewswire/ --

Optimer Pharmaceuticals to Present at the 11th Annual Needham Healthcare Conference

[ ]

SAN DIEGO, March 28, 2012 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: [ OPTR ]) today announced that the Company will present at the 11th Annual Needham Healthcare Conference on Tuesday, April 3 at 3:20 p.m. Eastern Time in New York, NY.

(Logo:  [ http://photos.prnewswire.com/prnh/20090413/LA97352LOGO ])

A live audio webcast of the presentation will be accessible on the Investors page of the Company's website at [ www.optimerpharma.com ].  Replays of the presentation will be available at the same location for 90 days following the presentation.

About Optimer Pharmaceuticals

Optimer Pharmaceuticals, Inc. is a global biopharmaceutical company focused on discovering, developing and commercializing innovative hospital specialty products that have a positive impact on society. Optimer developed and commercialized DIFICID® (fidaxomicin) tablets, an FDA-approved antibacterial drug for the treatment of adult patients with Clostridium difficile-associated diarrhea (CDAD). Optimer has also received marketing authorization for fidaxomicin tablets in the European Union under the trade name DIFICLIR™. The company is seeking marketing authorization for fidaxomicin in Canada and is exploring marketing authorization in other parts of the world where C. difficile has emerged as a serious health problem, including Asia. Additional information can be found at [ http://www.optimerpharma.com ].

Contacts

Optimer Pharmaceuticals, Inc.
David Walsey, VP of Investor Relations and Corporate Communications
858-909-0736
[ Dwalsey@optimerpharma.com ]

Canale Communications
Jason I. Spark, Senior Vice President
619-849-6005
[ Jason@canalecomm.com ]

SOURCE Optimer Pharmaceuticals, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.optimerpharma.com ]

Contributing Sources